Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

Personalis 01-PS-001

Trial Overview

Official Title

Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I (B-STRONGER-I)

Study Purpose

Evaluate the correlation of Minimal Residual Disease detection by NeXT Personal CTA (a molecular test) to pathological Complete Response (pCR) after neoadjuvant chemotherapy (NAC) in stage I-III triple negative breast cancer (TNBC)

Diagnosis

Early stage 1-111 triple negative breast cancer

Eligibility

Documented early stage triple negative breast cancer not having started treatment

Intervention

Blood draw only

For more information visit, Clinicaltrials.gov

Key Participation Requirements
Trial Location(s)
Methodist Estabrook Cancer Center
Gender
male or female
Age
19 and older
Enrollment Status
Recruiting
Phase
Phase I
Methodist Health System Trial Code
01-PS-001